Corcept Therapeutics Inc

NAS:CORTHealthcareNASDAQ:NQUSMGSTOXX:EDD24BP

$112.10+1.76%At closeAt close · Tue 20 Oct · ≈ AED 411.69 · Market cap $12.12B · Next earnings Tue 3 Nov · Extended $112.45 +0.31%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	98.4%	98.6%	98.7%	98.7%	98.4%	98.3%	—	—
Operating margin	36.2%	34.0%	28.0%	22.2%	20.3%	5.9%	5.9%	+0.0 pts
Net margin	30.0%	30.7%	25.2%	22.0%	20.7%	13.1%	13.1%	+0.0 pts
EBITDA margin	36.9%	35.0%	29.2%	26.0%	24.1%	9.0%	—	—
Return on equity	20.3%	29.9%	20.2%	20.9%	20.6%	15.4%	15.4%	+0.0 pts
Return on assets	18.5%	26.6%	17.4%	17.1%	16.6%	11.9%	11.9%	+0.0 pts
Return on capital employed	24.5%	33.1%	22.0%	20.8%	19.6%	6.7%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	0.4%	0.1%	0.2%	0.0%	0.8%	0.7%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	10.1×	5.6×	6.9×	4.4×	3.4×	2.9×	2.9×	+0.0%
Quick ratio	10.0×	5.5×	6.8×	4.3×	3.3×	2.8×	—	—
Cash ratio	1.6×	1.6×	0.9×	1.3×	0.9×	0.7×	0.7×	+0.0%
Asset turnover	0.6×	0.9×	0.7×	0.8×	0.8×	0.9×	—	—
Inventory turnover	1.1×	1.1×	0.9×	0.8×	0.9×	1.0×	—	—
Receivables turnover	13.5×	12.6×	8.6×	8.5×	11.6×	12.7×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.